Population-wide Research for HBV-related Liver Diseases in Maoming City
Conditions: HBV Infection; Chronic Hepatitis B; Cirrhosis; HCC Interventions: Other: Rapid tests for HBsAg Sponsors: Nanfang Hospital, Southern Medical University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 28, 2023 Category: Research Source Type: clinical trials
The Efficacy of Vosevi in Treating DAA-experienced Patients
Conditions: Chronic Hepatitis C; Antiviral Therapy Interventions: Drug: Sofosbuvir / Velpatasvir / Voxilaprevir Oral Tablet [Vosevi] Sponsors: The Third Affiliated Hospital of Guangzhou Medical University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 22, 2023 Category: Research Source Type: clinical trials
Partner Navigation Intervention for Hepatitis C Treatment Among Young People Who Inject Drugs
Conditions: Hepatitis C Interventions: Behavioral: Partner Navigation Intervention Sponsors: University of California, San Francisco; National Institute on Drug Abuse (NIDA) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 22, 2023 Category: Research Source Type: clinical trials
Peri-conceptional or Pregnancy Exposure of Vaccination and the Risk of Adverse Pregnancy Outcomes
Conditions: Vaccine Adverse Reaction Interventions: Biological: Hepatitis B vaccine, rabies vaccine, HPV vaccine, influenza vaccine Sponsors: Sun Xin Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 22, 2023 Category: Research Source Type: clinical trials
A Phase I, The Study to Evaluate the Safety, Immunogenicity and Efficacy of YS-HBV-002
Conditions: Chronic Hepatitis b Interventions: Biological: YS-HBV-002 Sponsors: Yisheng Biopharma (Singapore) Pte. Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 8, 2023 Category: Research Source Type: clinical trials
A Clinical Trial of TQ-A3334 Tablet After Multiple Administration in Adult Subjects
Conditions: Hepatitis B Interventions: Drug: TQ-A3334 tablets; Drug: TQ-A3334 placebo tablets Sponsors: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 7, 2023 Category: Research Source Type: clinical trials
Intestinal Microbiota Profiling in Severe Acute Alcoholic Hepatitis Patients
Conditions: Severe Acute Alcoholic Hepatitis; Alcohol; Intestinal Microbiota; Corticosteroids Interventions: Other: stool withdrawal Sponsors: Centre Hospitalier Universitaire, Amiens; CH Montdidier Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 6, 2023 Category: Research Source Type: clinical trials
A Clinical Study of 162 in Subjects With Chronic Hepatitis B Virus Infection
Conditions: Chronic Hepatitis B Virus Infection Interventions: Drug: 162; Drug: Placebo Sponsors: Yangshengtang Co., Ltd Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 6, 2023 Category: Research Source Type: clinical trials
Simplifying Hepatitis C Pathways for People Who Inject Drugs in Armenia, Georgia, and Tanzania
Conditions: Hepatitis C; RDT Interventions: Drug: sofosbuvir/velpatasvir (SOF/VEL); Diagnostic Test: Shortened read time of rapid diagnostic test for hepatitis C virus. Sponsors: M édecins du Monde; UNITAID; Burnet Institute; University of Bristol; International Network of People who Use Drugs Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 6, 2023 Category: Research Source Type: clinical trials
Intrahepatic and Peripheral Responses to Imdusiran (AB-729) in Chronic Hepatitis B
Conditions: Chronic Hepatitis B Interventions: Drug: Imdusiran (AB-729) Sponsors: University of Maryland, Baltimore; Arbutus Biopharma Corporation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 4, 2023 Category: Research Source Type: clinical trials
Adult Screening for Hepatitis c and Linkage to Treatment in Hospitals in Colombia
Conditions: Hepatitis C Virus Infection Interventions: Diagnostic Test: rapid diagnostic test HCV Ab Plus Rapid test Sponsors: Asociaci ón Colombiana de Hepatología; Hospital Pablo Tobón Uribe Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 4, 2023 Category: Research Source Type: clinical trials
Role of Extended Low Dose Prednisolone in Achieving Clinical and Biochemical Remission in Steroid Responsive Severe Alcoholic Hepatitis
Conditions: Severe Alcoholic Hepatitis Interventions: Drug: Prednisolone; Other: Standard Medical therapy; Drug: Placebo Sponsors: Institute of Liver and Biliary Sciences, India Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 4, 2023 Category: Research Source Type: clinical trials
The effect of switch therapy to tenofovir versus entecavir maintenance on recurrence of hepatocellular carcinoma after surgery (SWITE): study protocol for a randomized controlled trial
AbstractBackgroundAntiviral therapy has been reported to be associated with lower recurrence rate of hepatocellular carcinoma (HCC) for patients with hepatitis B virus (HBV) infection. While entecavir (ETV) and tenofovir disoproxil fumarate (TDF) were both recommended as first-line therapies for HBV patients, recent retrospective studies proposed a lower incidence rate of HCC occurrence or recurrence in those receiving TDF compared ETV. However, the survival benefits of switching to TDF therapy after prolonged ETV treatment before surgery remain uncertain. We delineate the rationale and design of SWITE, a randomized, open-...
Source: Trials - December 2, 2023 Category: Research Source Type: clinical trials
A Clinical Study of TQA3605 Tablets Monotherapy or in Combination With Nucleoside (Acid) Analogues in Treatment Naive and Treated Patients With Chronic Hepatitis B
Conditions: Chronic Hepatitis b Interventions: Drug: Placebo; Drug: TQA3605 tablets; Drug: Entecavir dispersible tablets; Drug: Tenofovir disoproxil fumarate tablet; Drug: Tenofovir alafenamide fumarate tablet Sponsors: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 29, 2023 Category: Research Source Type: clinical trials
A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Prophylactic Hepatitis B Vaccine
Conditions: Vaccine-Preventable Diseases; Hepatitis B Interventions: Biological: CVI-HBV-002 Sponsors: CHA Vaccine Institute Co., Ltd. Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 28, 2023 Category: Research Source Type: clinical trials
